: China COVID cases could double next month, as Merck antiviral gets approval

China’s health service approved an antiviral to treat COVID-19 as one health company estimates the country will see a doubling of its current wave of cases.

Previous post NerdWallet: How’s that bank working for you? Here’s how to set yourself up with the right account, tools and bank to fit your life.
Next post Economic Report: U.K. house prices see longest losing streak since global financial crisis, lender says